COVID-19 patients with acute respiratory distress syndrome (ARDS) had 14% differentially methylated genes in the promoter regions compared to healthy controls and they are involved in regulating immune pathways, such as IFN-γ and IFN-α [27]. This evidence concerns the gene IFNA1 and acute respiratory distress syndrome.